Sebaceous carcinoma of the eyelid in a patient with Muir-Torre syndrome treated with pembrolizumab: A case report

Patients with Muir-Torre Syndrome (MTS) are at increased risk of developing sebaceous carcinomas besides other visceral malignancies. Pembrolizumab is an effective therapy in patients with high microsatellite instability (MSI-H)/mismatch repair deficient (dMMR) tumors. We report a 70-year-old Caucas...

Full description

Bibliographic Details

Published in:	Current Problems in Cancer: Case Reports
Main Authors:	Ahmed Abdalla, Gabriel Roman Souza, Daruka Mahadevan
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Subjects:	Sebaceous carcinoma of the eyelid Muir-Torre syndrome Pembrolizumab
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666621922000205